Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
21.08.24
/
50%
€68.00
Target price
21.08.25
€72.78
Performance (%)
0.00%
Price
21.08.24
€68.00
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ is currently unchanged from the start price. This prediction currently runs until 21.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intra-Cellular Therapies Inc. | 0.00% |
iShares Core DAX® | 3.126% |
iShares Nasdaq 100 | 3.003% |
iShares Nikkei 225® | 4.991% |
iShares S&P 500 | 1.852% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at JPMorgan Chase & Co. from $79.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
12.06.24
12.06.24
€72.03
12.06.25
12.06.25
6.25%
21.08.24
21.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€41.80
09.03.23
09.03.23
€54.81
09.03.24
09.03.24
45.22%
10.03.24
10.03.24